Epofit Injectable

Get a Price/Quote

Product Details:

Salt Composition Recombinant Human Erythropoietin (EPO) Alfa
Dosage Form Injection (Prefilled Syringe)
Indication Anemia due to chronic renal failure, chemotherapy-induced anemia, anemia of prematurity, and to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery.
Enzyme Types Glycoprotein Cytokine (Erythropoiesis-stimulating agent)
Feature Sterile, preservative-free, ready-to-use prefilled syringe
Ingredients Recombinant Human Erythropoietin Alpha, Buffer solution (polysorbate 20, sodium chloride, sodium phosphate, human serum albumin, water for injection)
Application Parenteral use, subcutaneous or intravenous injection
Click to View more

Request to Call Back Send Inquiry

Product Details
Product Description

Epofit Injectable Price And Quantity

Packing Size 4000 IU/0.4 ml, 10000 IU/1 ml, and other strengths as available
Therapeutic Class Hormone replacement/anti-anemic agent
Prescription Status Prescription only (Rx) medicine
Batch Number & Manufacturing Date Printed on packaging
Administration Route Intravenous or Subcutaneous
USP/Pharmacopoeia Standard Conforms to Indian Pharmacopoeia (IP)/USP standards
Caution Use with caution in patients with history of seizures, hypertension, or pure red cell aplasia
Brand Name Epofit
Contraindications Uncontrolled hypertension, hypersensitivity to epoetin alfa or excipients
Packaging Type Single-dose prefilled syringe with safety needle

Epofit Injectable Product Specifications

Enzymatic Activity Stimulates red blood cell production by acting on erythroid progenitor cells
Application Parenteral use, subcutaneous or intravenous injection
Ph Level Approximately 6.8 - 7.4
Physical Color/Texture Clear, colorless solution
Shelf Life 24 months from date of manufacture
Storage Instructions Store at 2C to 8C (Refrigerated); Do not freeze. Protect from light.
Feature Sterile, preservative-free, ready-to-use prefilled syringe
Temperature Needed For Fermentation Not Applicable (Biotechnological fermentation product; fermentation parameters proprietary)
Dosage Form Injection (Prefilled Syringe)
Salt Composition Recombinant Human Erythropoietin (EPO) Alfa
Enzyme Types Glycoprotein Cytokine (Erythropoiesis-stimulating agent)
Ingredients Recombinant Human Erythropoietin Alpha, Buffer solution (polysorbate 20, sodium chloride, sodium phosphate, human serum albumin, water for injection)
Indication Anemia due to chronic renal failure, chemotherapy-induced anemia, anemia of prematurity, and to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery.
Fermentation Smell Odorless

Packing Size 4000 IU/0.4 ml, 10000 IU/1 ml, and other strengths as available
Therapeutic Class Hormone replacement/anti-anemic agent
Prescription Status Prescription only (Rx) medicine
Batch Number & Manufacturing Date Printed on packaging
Administration Route Intravenous or Subcutaneous
USP/Pharmacopoeia Standard Conforms to Indian Pharmacopoeia (IP)/USP standards
Caution Use with caution in patients with history of seizures, hypertension, or pure red cell aplasia
Brand Name Epofit
Contraindications Uncontrolled hypertension, hypersensitivity to epoetin alfa or excipients
Packaging Type Single-dose prefilled syringe with safety needle

Epofit Injectable Trade Information

Main Export Market(s) Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

Our organization has attained expertise in this domain in offering Epofit Injectable. It is used for treatment of anemia related to severe kidney disease and cancer chemotherapy for certain tumors. Our diligent agents procure this drug from the trusted vendors of the market. It is also used in anemic patients scheduled to have major bone surgery to reduce the need for blood transfusion. Packed in tamper proof packaging materials, Epofit Injectable is available in different strengths. We offer this drug at pocket friendly prices.

Features:

Extended shelf life
Accurate composition
Stimulates red blood cell production

Therapeutic Benefits

Epofit Injectable stimulates red blood cell production by acting on erythroid progenitor cells. This mechanism helps to correct anemia, improving oxygen carrying capacity and reducing the need for blood transfusions, especially in individuals with chronic renal failure, those undergoing chemotherapy, or premature infants.

Easy and Safe Administration

Delivered in a single-dose prefilled syringe with a safety needle, Epofit ensures convenient and precise dosing for both subcutaneous and intravenous routes. Its preservative-free composition reduces the risk of allergic reactions and it is supplied ready-to-use, streamlining the medication process for healthcare professionals.

Quality and Reliability

Manufactured to Indian Pharmacopoeia (IP) and USP standards, Epofit offers consistent quality and efficacy. Batch number and manufacturing date are clearly printed on every package for traceability, and the products 24-month shelf life ensures long-term storage stability when kept refrigerated as directed.

FAQs of Epofit Injectable:

Q: How should Epofit Injectable be administered?

A: Epofit should be administered either subcutaneously or intravenously, as advised by a healthcare professional. The medication is supplied in a single-dose prefilled syringe and must be injected under medical supervision to ensure safety and correct technique.

Q: What are the main medical uses of Epofit Injectable?

A: Epofit is primarily indicated for treating anemia due to chronic renal failure, chemotherapy-induced anemia, and anemia in premature infants. It is also prescribed to reduce the need for blood transfusions in patients undergoing elective surgery.

Q: When should Epofit not be used?

A: Epofit must not be used in individuals with uncontrolled hypertension or in those who are hypersensitive to epoetin alfa or any of the excipients. Its important to inform your doctor about any history of these conditions before starting therapy.

Q: What precautions should be taken during Epofit therapy?

A: Caution is advised in patients with a history of seizures, hypertension, or pure red cell aplasia. Regular monitoring of blood pressure and hemoglobin levels is crucial, and therapy should always be conducted under medical supervision.

Q: Where should Epofit Injectable be stored?

A: Epofit must be kept refrigerated at 2C to 8C and protected from light. It should never be frozen. Always keep the product in its original packaging until ready to use.

Q: How does Epofit benefit patients with anemia?

A: Epofit acts as an erythropoiesis-stimulating agent, promoting red blood cell production and improving hemoglobin levels. This alleviates symptoms such as fatigue and weakness, supporting improved quality of life and reducing reliance on transfusions.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

Other Products in 'Anti Cancer Injections' category

Irinotecan Injection Feature : Other, Sterile, singleuse vial, readytouse solution Storage Instructions : Store below 25C, protect from light Physical Color/Texture : Other , Clear to pale yellow solution Shelf Life : 24 36 months Application : Other, Hospital, Clinical, Oncology center usage Indication : Used in the treatment of metastatic colorectal cancer and other solid tumors Ingredients : Other , Irinotecan Hydrochloride Trihydrate, excipients, water for injection Salt Composition : Irinotecan Hydrochloride Trihydrate Dosage Form : Injection Fermentation Smell : Other, Odorless Ph Level : 3.5 3.8

Send Inquiry

Taxotere Injection Feature : Other, Single use vial, Sterile, Preservative free Storage Instructions : Store below 25C. Protect from light. Do not freeze. Physical Color/Texture : Other , Clear to pale yellow solution Shelf Life : 24 months Application : Other, Antineoplastic (Chemotherapy) Indication : Breast cancer, Nonsmall cell lung cancer, Prostate cancer, Gastric adenocarcinoma, Head and neck cancer Ingredients : Other , Docetaxel, Polysorbate 80, Ethanol, Water for Injection Salt Composition : Docetaxel (anhydrous) Dosage Form : Injection Fermentation Smell : Other, Odorless Ph Level : Neutral

Send Inquiry

Oncotaxel Injection Feature : Other, Readytouse, singledose vial, sterile Storage Instructions : Store between 225C, protect from light, do not freeze Physical Color/Texture : Other , Clear yellow to brownishyellow solution Shelf Life : 2 years from the date of manufacture Application : Other, Antineoplastic agent, administered intravenously under medical supervision Indication : Breast cancer, Nonsmall cell lung cancer, Prostate cancer, Stomach cancer, Head and neck cancer Ingredients : Other , Docetaxel, polysorbate 80, ethanol Salt Composition : Docetaxel (as trihydrate) Dosage Form : Injection Fermentation Smell : Other, Ethanollike odor

Send Inquiry

Leucovorin Calcium Injection Feature : Other, Sterile, readytouse, pyrogenfree Storage Instructions : Store below 25C, protect from light Physical Color/Texture : Other , Clear, colorless liquid Shelf Life : 24 months Application : Other, Medical, Oncology, Chemotherapy adjunct Indication : Rescue agent after highdose methotrexate therapy, reduction of toxic effects of methotrexate Ingredients : Other , Leucovorin Calcium, Water for Injection, stabilizers Salt Composition : Leucovorin Calcium Dosage Form : Injection Fermentation Smell : Other, Odorless Ph Level : Neutral (approximately pH 7.5)

Send Inquiry

SEND INQUIRY CALL ME FREE

We Mainly Deal in International Market.